| Title |
Enhancing Pharmacosurveillance with Systematic Collection of Treatment Indication in Electronic Prescribing
|
|---|---|
| Published in |
Drug Safety, December 2012
|
| DOI | 10.2165/11534580-000000000-00000 |
| Pubmed ID | |
| Authors |
Tewodros Eguale, Nancy Winslade, James A. Hanley, David L. Buckeridge, Robyn Tamblyn |
| Abstract |
Adverse drug reaction reports used in pharmacosurveillance often lack complete information on treatment indication that is important for benefit-risk analyses and clinical and regulatory decision making. A systematic documentation of treatment indication using electronic prescribing applications provides an opportunity to develop new pharmacosurveillance tools that will allow evaluation of drugs by weighing benefits and risks for specific indications, and evaluate off-label prescribing. In addition, interfacing indications with reminders and clinical guidelines can enhance clinical decision making. We investigated the validity of treatment indications documented using an electronic prescribing system at the time of prescribing. |
Mendeley readers
The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 1% |
| Germany | 1 | 1% |
| Unknown | 93 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 18 | 19% |
| Student > Master | 14 | 15% |
| Student > Bachelor | 11 | 12% |
| Researcher | 9 | 9% |
| Student > Doctoral Student | 9 | 9% |
| Other | 24 | 25% |
| Unknown | 10 | 11% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 39 | 41% |
| Nursing and Health Professions | 9 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 7% |
| Psychology | 6 | 6% |
| Biochemistry, Genetics and Molecular Biology | 3 | 3% |
| Other | 15 | 16% |
| Unknown | 16 | 17% |
Attention Score in Context
This research output has an Altmetric Attention Score of 23. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 February 2016.
All research outputs
#1,629,335
of 25,373,627 outputs
Outputs from Drug Safety
#154
of 1,852 outputs
Outputs of similar age
#14,360
of 288,569 outputs
Outputs of similar age from Drug Safety
#39
of 604 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,852 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.9. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 288,569 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 604 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.